Showing results (1-10 of 384) with videos related to
Sort By:
Pageof 39
Expert Opinion on Drug Safety|March 30, 2005
The development and application of imatinibRobin L Jones, Ian R JudsonEuropean Journal of Cancer (Oxford, England : 1990)|November 18, 2005
Differential sensitivity of liposarcoma subtypes to chemotherapyRobin L Jones, Cyril Fisher, Omar Al-Muderis, et al.Cancer Journal (Sudbury, Mass.)|June 8, 2010
Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedsideDavid Olmos, Daniel S W Tan, Robin L Jones, et al.Sarcoma|June 8, 2011
Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsDavid Olmos, Ana Sofia Martins, Robin L Jones, et al.American Journal of Clinical Oncology|March 23, 2011
Role of palliative chemotherapy in advanced epithelioid sarcomaRobin L Jones, Anastasia Constantinidou, David Olmos, et al.Sarcoma|May 29, 2010
Clinical benefit of second-line palliative chemotherapy in advanced soft-tissue sarcomaAnna Minchom, Robin L Jones, Cyril Fisher, et al.Cancer Chemotherapy and Pharmacology|November 12, 2010
Clinical benefit of early phase clinical trial participation for advanced sarcoma patientsRobin L Jones, David Olmos, Khin Thway, et al.Expert Review of Cardiovascular Therapy|November 21, 2008
Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicityRobin L JonesFuture Oncology (London, England)|September 11, 2019
Sarcomas and old age: few options for such a large patient populationRobin L JonesFuture Oncology (London, England)|December 8, 2016
Understanding sarcomas and other rare tumors: an interview with Robin L JonesRobin L JonesPageof 39